Preclinical evidence of reno-protective effect of quercetin on acute kidney injury: a meta-analysis of animal studies
Frontiers in Pharmacology · 22.12.2023 · 14
DOI: 10.3389/fphar.2023.1310023 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 22.12.2023. Verfasst von Yi-Fan Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Hunan Province of China, Fundamental Research Funds for Central Universities of the Central South University, Hunan Provincial Innovation Foundation for Postgraduate.
Abstract (Originalsprache)
Objective
This study evaluated the reno-protective effects of quercetin in animal models of acute kidney injury (AKI).
Methods
We conducted a systematic search of literature published before April 2023 in PubMed, Web of Science, and EMBASE databases. Methodological quality was assessed by SYRCLE’s RoB tool. Funnel plot, Egger’s test, and Begg’s test were used to determine publication bias.
Results
A total of 19 studies with 288 animals were included in this meta-analysis. The methodology quality scores of the included studies ranged from 4 to 7. The results indicated that quercetin reduced blood urea nitrogen (SMD = −4.78; 95% CI: 6.45, −3.12; p < 0.01; I 2 = 84%) and serum creatinine (SMD: 2.73, 95% CI: 3.66, −1.80; p < 0.01; I 2 = 80%) in AKI models. The result of sensitivity analysis was stable, while the results of funnel plot indicated asymmetric. In addition, we further analyzed inflammatory cytokines, oxidative stress levels, and kidney injury scores, and found that quercetin treatment had antioxidant and anti-inflammatory effects and improved kidney injury scores in animal models of AKI.
Conclusion
Quercetin exhibited a promising reno-protective effect in AKI animal models. Systematic Review Registration: PROSPERO (CRD42023433333).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
- Department of Pharmacy, Hunan Chest Hospital, Changsha Medical University, Changsha, China.
Förderung
- Key Research and Development Program of Hunan Province of China
- Fundamental Research Funds for Central Universities of the Central South University
- Hunan Provincial Innovation Foundation for Postgraduate
Zitieren
APA
Zeng, Y. F., Li, J. Y., Wei, X. Y., Ma, S. Q., Wang, Q. G., Qi, Z., Duan, Z. C., Tan, L., & Tang, H. (2023). Preclinical evidence of reno-protective effect of quercetin on acute kidney injury: a meta-analysis of animal studies. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1310023
Vancouver
Zeng YF, Li JY, Wei XY, Ma SQ, Wang QG, Qi Z, et al. Preclinical evidence of reno-protective effect of quercetin on acute kidney injury: a meta-analysis of animal studies. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1310023
BibTeX
@article{Zeng2023,
author = {Zeng, Yi-Fan and Li, Jing-Yu and Wei, Xin-Yu and Ma, Si-Qing and Wang, Qiu-Guo and Qi, Zhen and Duan, Zhi-Cheng and Tan, Ling and Tang, Hao},
title = {Preclinical evidence of reno-protective effect of quercetin on acute kidney injury: a meta-analysis of animal studies},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1310023}
}
EUVIMED